YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer

Alastair H. Davies, Kristen M. Reipas, Mary Rose Pambid, Rachel Berns, Anna L. Stratford, Abbas Fotovati, Natalie Firmino, Arezoo Astanehe, Kaiji Hu, Christopher Maxwell, Gordon Mills, Sandra E. Dunn

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

There is growing evidence that cancer-initiation could result from epigenetic changes. Y-box binding protein-1 (YB-1) is a transcription/ translation factor that promotes the formation of tumors in transgenic mice; however, the underlying molecular events are not understood. To explore this in a human model system, YB-1 was expressed in mammary epithelial cells under the control of a tetracycline-inducible promoter. The induction of YB-1 promoted phenotypes associated with malignancy in three-dimensional breast acini cultures. This was attributed to YB-1 enhancing the expression and activity of the histone acetyltransferase p300 leading to chromatin remodeling. Specifically, this relaxation of chromatin allowed YB-1 to bind to the BMI1 promoter. The induction of BMI1 engaged the Polycomb complex resulting in histone H2A ubiquitylation and repression of the CDKN2A locus. These events manifested functionally as enhanced self-renewal capacity that occurred in a BMI1-dependent manner. Conversely, p300 inhibition with anacardic acid prevented YB-1 from binding to the BMI1 promoter and thereby subverted self-renewal. Despite these early changes, full malignant transformation was not achieved until RSK2 became overexpressed concomitant with elevated human telomerase reverse transcriptase (hTERT) activity. The YB-1/RSK2/hTERT expressing cells formed tumors in mice that were molecularly subtyped as basal-like breast cancer. We conclude that YB-1 cooperates with p300 to allow BMI1 to over-ride p16INK4a-mediated cell cycle arrest enabling self-renewal and the development of aggressive breast tumors. Stem Cells 2014;32:1437-1450

Original languageEnglish (US)
Pages (from-to)1437-1450
Number of pages14
JournalStem Cells
Volume32
Issue number6
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Chromatin Assembly and Disassembly
Breast
Epithelial Cells
Breast Neoplasms
Neoplasms
Y-Box-Binding Protein 1
Histone Acetyltransferases
Ubiquitination
Cell Cycle Checkpoints
Tetracycline
Epigenomics
Histones
Transgenic Mice
Chromatin
Transcription Factors
Stem Cells
Phenotype
human TERT protein

Keywords

  • Breast cancer
  • Cancer stem cells
  • Epigenetics
  • Human mammary epithelial cells
  • Neoplastic cell transformation
  • Y-box binding protein-1

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Molecular Medicine
  • Medicine(all)

Cite this

Davies, A. H., Reipas, K. M., Pambid, M. R., Berns, R., Stratford, A. L., Fotovati, A., ... Dunn, S. E. (2014). YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer. Stem Cells, 32(6), 1437-1450. https://doi.org/10.1002/stem.1707

YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer. / Davies, Alastair H.; Reipas, Kristen M.; Pambid, Mary Rose; Berns, Rachel; Stratford, Anna L.; Fotovati, Abbas; Firmino, Natalie; Astanehe, Arezoo; Hu, Kaiji; Maxwell, Christopher; Mills, Gordon; Dunn, Sandra E.

In: Stem Cells, Vol. 32, No. 6, 01.01.2014, p. 1437-1450.

Research output: Contribution to journalArticle

Davies, AH, Reipas, KM, Pambid, MR, Berns, R, Stratford, AL, Fotovati, A, Firmino, N, Astanehe, A, Hu, K, Maxwell, C, Mills, G & Dunn, SE 2014, 'YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer', Stem Cells, vol. 32, no. 6, pp. 1437-1450. https://doi.org/10.1002/stem.1707
Davies, Alastair H. ; Reipas, Kristen M. ; Pambid, Mary Rose ; Berns, Rachel ; Stratford, Anna L. ; Fotovati, Abbas ; Firmino, Natalie ; Astanehe, Arezoo ; Hu, Kaiji ; Maxwell, Christopher ; Mills, Gordon ; Dunn, Sandra E. / YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer. In: Stem Cells. 2014 ; Vol. 32, No. 6. pp. 1437-1450.
@article{1a3becae4ff044e8a490424c47ddf773,
title = "YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer",
abstract = "There is growing evidence that cancer-initiation could result from epigenetic changes. Y-box binding protein-1 (YB-1) is a transcription/ translation factor that promotes the formation of tumors in transgenic mice; however, the underlying molecular events are not understood. To explore this in a human model system, YB-1 was expressed in mammary epithelial cells under the control of a tetracycline-inducible promoter. The induction of YB-1 promoted phenotypes associated with malignancy in three-dimensional breast acini cultures. This was attributed to YB-1 enhancing the expression and activity of the histone acetyltransferase p300 leading to chromatin remodeling. Specifically, this relaxation of chromatin allowed YB-1 to bind to the BMI1 promoter. The induction of BMI1 engaged the Polycomb complex resulting in histone H2A ubiquitylation and repression of the CDKN2A locus. These events manifested functionally as enhanced self-renewal capacity that occurred in a BMI1-dependent manner. Conversely, p300 inhibition with anacardic acid prevented YB-1 from binding to the BMI1 promoter and thereby subverted self-renewal. Despite these early changes, full malignant transformation was not achieved until RSK2 became overexpressed concomitant with elevated human telomerase reverse transcriptase (hTERT) activity. The YB-1/RSK2/hTERT expressing cells formed tumors in mice that were molecularly subtyped as basal-like breast cancer. We conclude that YB-1 cooperates with p300 to allow BMI1 to over-ride p16INK4a-mediated cell cycle arrest enabling self-renewal and the development of aggressive breast tumors. Stem Cells 2014;32:1437-1450",
keywords = "Breast cancer, Cancer stem cells, Epigenetics, Human mammary epithelial cells, Neoplastic cell transformation, Y-box binding protein-1",
author = "Davies, {Alastair H.} and Reipas, {Kristen M.} and Pambid, {Mary Rose} and Rachel Berns and Stratford, {Anna L.} and Abbas Fotovati and Natalie Firmino and Arezoo Astanehe and Kaiji Hu and Christopher Maxwell and Gordon Mills and Dunn, {Sandra E.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/stem.1707",
language = "English (US)",
volume = "32",
pages = "1437--1450",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "6",

}

TY - JOUR

T1 - YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer

AU - Davies, Alastair H.

AU - Reipas, Kristen M.

AU - Pambid, Mary Rose

AU - Berns, Rachel

AU - Stratford, Anna L.

AU - Fotovati, Abbas

AU - Firmino, Natalie

AU - Astanehe, Arezoo

AU - Hu, Kaiji

AU - Maxwell, Christopher

AU - Mills, Gordon

AU - Dunn, Sandra E.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - There is growing evidence that cancer-initiation could result from epigenetic changes. Y-box binding protein-1 (YB-1) is a transcription/ translation factor that promotes the formation of tumors in transgenic mice; however, the underlying molecular events are not understood. To explore this in a human model system, YB-1 was expressed in mammary epithelial cells under the control of a tetracycline-inducible promoter. The induction of YB-1 promoted phenotypes associated with malignancy in three-dimensional breast acini cultures. This was attributed to YB-1 enhancing the expression and activity of the histone acetyltransferase p300 leading to chromatin remodeling. Specifically, this relaxation of chromatin allowed YB-1 to bind to the BMI1 promoter. The induction of BMI1 engaged the Polycomb complex resulting in histone H2A ubiquitylation and repression of the CDKN2A locus. These events manifested functionally as enhanced self-renewal capacity that occurred in a BMI1-dependent manner. Conversely, p300 inhibition with anacardic acid prevented YB-1 from binding to the BMI1 promoter and thereby subverted self-renewal. Despite these early changes, full malignant transformation was not achieved until RSK2 became overexpressed concomitant with elevated human telomerase reverse transcriptase (hTERT) activity. The YB-1/RSK2/hTERT expressing cells formed tumors in mice that were molecularly subtyped as basal-like breast cancer. We conclude that YB-1 cooperates with p300 to allow BMI1 to over-ride p16INK4a-mediated cell cycle arrest enabling self-renewal and the development of aggressive breast tumors. Stem Cells 2014;32:1437-1450

AB - There is growing evidence that cancer-initiation could result from epigenetic changes. Y-box binding protein-1 (YB-1) is a transcription/ translation factor that promotes the formation of tumors in transgenic mice; however, the underlying molecular events are not understood. To explore this in a human model system, YB-1 was expressed in mammary epithelial cells under the control of a tetracycline-inducible promoter. The induction of YB-1 promoted phenotypes associated with malignancy in three-dimensional breast acini cultures. This was attributed to YB-1 enhancing the expression and activity of the histone acetyltransferase p300 leading to chromatin remodeling. Specifically, this relaxation of chromatin allowed YB-1 to bind to the BMI1 promoter. The induction of BMI1 engaged the Polycomb complex resulting in histone H2A ubiquitylation and repression of the CDKN2A locus. These events manifested functionally as enhanced self-renewal capacity that occurred in a BMI1-dependent manner. Conversely, p300 inhibition with anacardic acid prevented YB-1 from binding to the BMI1 promoter and thereby subverted self-renewal. Despite these early changes, full malignant transformation was not achieved until RSK2 became overexpressed concomitant with elevated human telomerase reverse transcriptase (hTERT) activity. The YB-1/RSK2/hTERT expressing cells formed tumors in mice that were molecularly subtyped as basal-like breast cancer. We conclude that YB-1 cooperates with p300 to allow BMI1 to over-ride p16INK4a-mediated cell cycle arrest enabling self-renewal and the development of aggressive breast tumors. Stem Cells 2014;32:1437-1450

KW - Breast cancer

KW - Cancer stem cells

KW - Epigenetics

KW - Human mammary epithelial cells

KW - Neoplastic cell transformation

KW - Y-box binding protein-1

UR - http://www.scopus.com/inward/record.url?scp=84901437825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901437825&partnerID=8YFLogxK

U2 - 10.1002/stem.1707

DO - 10.1002/stem.1707

M3 - Article

C2 - 24648416

AN - SCOPUS:84901437825

VL - 32

SP - 1437

EP - 1450

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 6

ER -